1 in 10 people
Struggle with substance use disorders (SUD) and over 54 million worldwide haveturned to prescription drugs for
PATIENT WELL BEING AND OPIOD ADDICTION IS
Do you have a plan?
According to The National Institute on Drug Abuse, 80% of Americans came in contact with a health care professional in the past year, making doctors first responders to the latest epidemic
We equip physicians with advanced and emerging quantitative laboratory science to deliver undeniable value to all stakeholders in healthcare; Patients, communities, insurance carriers, and healthcare regulators
The business of good science has just met the demand for value
As America is in the grip of overlapping healthcare epidemics,
Quantox is teaming up with providers nationwide
As [SUDs] are on the rise, patients across all demographics are struggling to cope with the overwhelming stresses of addiction. While OPIODS are the hot topic of conversation in the medicine today, there is a lower concern for adherence to other types of medication management.
Disparate health systems are failing to capture and share accurate patient level prescription and treatment information across provider treatment environments, This further exacerbates extended use of ineffective prescriptions, misdiagnosis, and adverse side effects of undisclosed self-medication.
The Underlying Risk of
As patients are treated across multiple specialties for different ailments, often overlooked is the entire spectrum of prescriptions they are taking on an ongoing basis. These instances are often overlooked and proper medication management of a patient's regiment mitigates probable adverse side effects.
Mounting pressure from insurance carriers continually shifting the payment environment has removed physicians' treatment autonomy.
Drug Resistance and Antibiotic Overuse
As demand for prompt care grows, patients are saying goodbye to their primary care providers. Leaving physicians over prescribing antibiotics for common ailments. Resulting in Antibiotic resistant Strep, C-dif, UTI, STD's, MRSA and a host of others require higher level diagnostics typically unavailable to front line providers.
Overburdened physicians are left with insufficient methods of identifying SUDs, polypharmacy and infectious disease